DNA Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global DNA Sequencing Products Market Growth & Companies. The Market is Segmented by Product Type (Instruments, Consumables, and Other Product Types), Sequencing Type (Sanger Sequencing, Next-Generation Sequencing, and Other Sequencing Types), Application (Diagnostics, Personalized Medicine, and Other Applications), End User (Hospitals and Healthcare Organizations, Academics and Research Institutions, Pharmaceutical and Biotechnology Companies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Value is Provided in (USD Million) for the Above Segments.

DNA Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

DNA Sequencing Market Size

DNA Sequencing Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 14.40 Billion
Market Size (2030) USD 34.23 Billion
CAGR (2025 - 2030) 18.91 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

DNA Sequencing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of DNA Sequencing Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

DNA Sequencing Market Analysis

The DNA Sequencing Market size is estimated at USD 14.40 billion in 2025, and is expected to reach USD 34.23 billion by 2030, at a CAGR of 18.91% during the forecast period (2025-2030).

The DNA sequencing industry continues to undergo significant transformation as emerging platforms and technologies reshape the competitive landscape. The sector has witnessed substantial private investment activity, exemplified by a California-based genomics startup securing USD 600 million in funding in July 2022 to deliver whole human genome sequencing at the groundbreaking price point of USD 100. This development signals growing investor confidence in next-generation sequencing technologies and highlights the industry's movement toward more accessible and affordable genomic analysis solutions.


The DNA sequencing market landscape is experiencing a shift toward more integrated and automated solutions that combine hardware, software, and analytical capabilities. This evolution is evident in the launch of innovative platforms like Singular Genomics Systems' G4 benchtop sequencer in December 2021, which introduced revolutionary high-performance chemistry and advanced engineering capabilities. These integrated solutions are particularly focused on addressing specific research applications in fields such as oncology and immunology, demonstrating the industry's movement toward more specialized and targeted sequencing solutions.


The adoption of DNA sequencing technologies has expanded beyond traditional research institutions into broader commercial and clinical applications. According to research published in the Journal of Pure and Applied Microbiology in June 2022, DNA sequencing methods have evolved significantly to meet the demanding requirements of both clinical diagnostic laboratories and research facilities, enabling high-quality results that directly impact patient care. This expansion has led to the development of more robust and standardized protocols for sequence analysis and interpretation.


The industry is witnessing increased collaboration between public and private entities to establish large-scale genomic databases and biorepositories. This trend is illustrated by initiatives like India's Department of Biotechnology's establishment of five COVID-19 biorepositories containing 57,000 samples made available to academia and industry for R&D and product development. Such collaborative efforts are essential for advancing genomic research and developing new applications across various fields, from personalized medicine to population genetics studies. These partnerships are creating valuable resources for researchers while simultaneously driving innovation in sequencing technologies and analytical methods.

Segment Analysis: By Product Type

Consumables Segment in DNA Sequencing Market

The consumables segment, which includes kits and reagents, dominates the DNA sequencing market with approximately 58% market share in 2024. This segment's prominence is driven by the recurring nature of consumable purchases required for DNA sequencing processes, including sample preparation, DNA isolation, sample cleanup, and various enzymatic reactions. The segment encompasses essential components like DNA polymerase, phosphorylation buffer, adapters, ligators, ligase enzyme, and ligase buffer that are crucial throughout the sequencing workflow. Major market players have been actively expanding their DNA sequencing products portfolio through new product launches and innovations. For instance, in 2024, companies are focusing on developing more efficient and cost-effective reagent kits that can improve sequencing accuracy while reducing processing time. The segment's growth is further supported by the increasing adoption of next-generation sequencing technologies in clinical diagnostics, research institutions, and pharmaceutical companies.

Market Analysis of DNA Sequencing Market: Chart for By Product Type

Instruments Segment in DNA Sequencing Market

The instruments segment represents a crucial component of the DNA sequencing market, encompassing various sequencing platforms from traditional Sanger sequencers to advanced next-generation sequencing instruments. The segment's growth is primarily driven by technological advancements in sequencing equipment, leading to improved accuracy, speed, and throughput capabilities. Modern DNA sequencing instruments have significantly contributed to the sequencing of complete DNA sequences and genomes of different types and species of life. The continuous innovation in instrument design and capabilities, coupled with the increasing demand for high-throughput sequencing solutions in research and clinical applications, is expected to maintain strong growth momentum in this segment through 2029.

Remaining Segments in DNA Sequencing Market by Product Type

The other product types segment in the DNA sequencing market encompasses various supporting products and services, including data analysis tools, software solutions, and cloud computing services related to DNA sequencing. This segment plays a vital role in the overall sequencing workflow by providing essential bioinformatics support and data management capabilities. The segment includes services for RNA sequencing, whole-exome sequencing, whole-genome sequencing, targeted sequencing, and various other specialized applications. The increasing complexity of genomic data analysis and the growing need for sophisticated data interpretation tools continue to drive innovation in this segment, making it an integral part of the DNA sequencing ecosystem.

Segment Analysis: By Sequencing Type

Next Generation Sequencing Segment in DNA Sequencing Market

Next Generation Sequencing (NGS) continues to dominate the DNA sequencing market, commanding approximately 83% of the total market share in 2024. This significant market position can be attributed to NGS technology's ability to provide faster, more cost-effective, and highly accurate sequencing results compared to traditional methods. The technology's widespread adoption in clinical diagnostics, drug discovery, and personalized medicine has been further accelerated by its crucial role in genomic surveillance and variant detection during the COVID-19 pandemic. Major market players like Illumina, Thermo Fisher Scientific, and Roche have been instrumental in advancing NGS technologies through continuous innovation and development of more efficient sequencing platforms that offer improved throughput and reduced sequencing costs.

Other Sequencing Types Segment in DNA Sequencing Market

The Other Sequencing Types segment, which includes emerging technologies like Nanopore sequencing and Single-molecule real-time (SMRT) sequencing, is experiencing the fastest growth trajectory in the DNA sequencing market. These third-generation sequencing technologies are revolutionizing the field with their ability to sequence longer DNA fragments and provide real-time results. The segment's rapid expansion is driven by increasing adoption in research applications, particularly in studying complex genomic regions and structural variations. Companies like Oxford Nanopore Technologies and Pacific Biosciences are leading innovation in this space, developing portable sequencing devices and improving accuracy rates, which is expected to maintain the segment's strong growth momentum through 2024-2029.

Remaining Segments in DNA Sequencing Market by Sequencing Type

Sanger Sequencing, while representing a smaller portion of the market, continues to maintain its relevance as the gold standard for validation of DNA sequences and smaller-scale projects. Despite being the oldest DNA sequencing technology, it remains crucial for specific applications where high accuracy is paramount, particularly in clinical diagnostics and validation of Next-Generation Sequencing results. The technology's reliability and established protocols make it an indispensable tool in many research laboratories and diagnostic facilities, especially for targeted sequencing of specific genes or DNA regions where its accuracy rate of 99.99% is particularly valuable.

Segment Analysis: By Application

Diagnostics Segment in DNA Sequencing Market

The Diagnostics segment has emerged as a dominant force in the global DNA sequencing market, accounting for approximately 30% of the total market share in 2024. This significant market position is driven by the widespread adoption of DNA sequencing in clinical laboratories worldwide as the gold standard for diagnosing hereditary disorders, owing to its analytical accuracy, high throughput capabilities, and potential for cost-effectiveness. The segment's prominence is further strengthened by the crucial role DNA sequencing plays in diagnosing infectious pathogens, cancer diagnostics, and complex diseases including schizophrenia, macular degeneration, and neurodegenerative conditions. The increasing focus by key industry players on launching innovative DNA sequencing products specifically for diagnostic applications has also contributed to this segment's market leadership, with companies developing comprehensive diagnostic tools that leverage advanced sequencing technologies for more accurate and efficient disease detection and characterization.

Personalized Medicine Segment in DNA Sequencing Market

The Personalized Medicine segment is demonstrating remarkable growth potential in the DNA sequencing market, with projections indicating an impressive growth rate of approximately 20% during the forecast period 2024-2029. This accelerated growth is primarily driven by the increasing adoption of personalized therapeutics across the globe and the rising importance of DNA sequencing in developing targeted treatments for patients who do not respond to standard care protocols, particularly in cancer treatment and rare diseases. The segment's expansion is further fueled by the successful exploration of DNA sequencing in developing a range of cancer genetic tests and predictive testing for various hereditary conditions. The advancement in DNA sequencing technologies has enabled more precise identification of genetic variants associated with diseases, allowing healthcare providers to tailor treatments to individual patients' genetic profiles, thereby improving therapeutic outcomes and patient care efficiency.

Remaining Segments in DNA Sequencing Market by Application

Beyond diagnostics and personalized medicine, the DNA sequencing market encompasses several other crucial applications, including biomarker discovery, forensics, and reproductive health. The biomarker segment has become increasingly important in the discovery of new indicators for infectious diseases and cancers, leading to the development of new diagnostic and therapeutic targets. In forensics, DNA sequencing has revolutionized investigative procedures through advanced analysis capabilities, particularly in human identification and evidence examination. The reproductive health application has gained significant traction with the integration of DNA sequencing in preconception screening, fertility treatments, and genetic disorder detection, demonstrating the versatility and expanding scope of DNA sequencing technologies across different healthcare domains.

Segment Analysis: By End User

Academics and Research Institutions Segment in DNA Sequencing Market

The Academics and Research Institutions segment continues to dominate the global DNA sequencing market, holding approximately 41% market share in 2024. This segment's prominence is driven by extensive use of DNA sequencing technologies in various research applications, particularly in oncology and drug discovery studies, which has revolutionized biological and medical research. Academic institutions worldwide are increasingly incorporating DNA sequencing into their genomics courses and research programs, preparing students for the growing importance of genomic data in biological and medical research. The segment's leadership position is further strengthened by its crucial role in identifying changes in genes, associations with diseases, and phenotypes, which aids in discovering potential drug targets. Additionally, academic research institutions are at the forefront of using DNA sequencing to detect mutations in DNA sequences and understand the physiological and pathological effects of mutations on individual health outcomes.

Pharmaceutical and Biotechnology Companies Segment in DNA Sequencing Market

The Pharmaceutical and Biotechnology Companies segment is emerging as the fastest-growing segment in the DNA sequencing market, with robust growth projected for 2024-2029. This exceptional growth is driven by the increasing adoption of DNA sequencing in drug development processes, enabling pharmaceutical companies to take a more personalized approach toward drug development and discovery of safer and more effective medicines. The segment's rapid expansion is further fueled by the rising implementation of DNA sequencing at various stages of drug development, as these technologies provide unique opportunities to improve the discovery of novel therapeutic targets and facilitate precise design of clinical trials on target populations. Additionally, biotechnology companies are increasingly leveraging DNA sequencing technologies for developing diagnostic kits and assays for various disease detection applications, contributing to the segment's accelerated growth trajectory.

Remaining Segments in DNA Sequencing Market by End User

The remaining segments in the DNA sequencing market include Hospitals and Healthcare Organizations and Other End Users, each playing vital roles in the market's ecosystem. The Hospitals and Healthcare Organizations segment is particularly significant as healthcare professionals increasingly rely on DNA sequencing for accurate disease diagnosis and treatment planning, especially in areas such as cancer detection and infectious diseases. The Other End Users segment encompasses non-profit organizations, biobanks, diagnostic laboratories, and in-vitro fertilization laboratories, which contribute to the market's diversity by utilizing DNA sequencing technologies for various specialized applications, from genetic testing to reproductive health services. These segments collectively enhance the market's reach and application scope, supporting the overall advancement of genomic medicine and personalized healthcare approaches.

DNA Sequencing Market Geography Segment Analysis

DNA Sequencing Market in North America

North America represents a dominant force in the global DNA sequencing market, encompassing the United States, Canada, and Mexico. The region's leadership position is attributed to its advanced healthcare infrastructure, substantial research and development activities, and the presence of major market players. The widespread adoption of next-generation sequencing technologies across healthcare organizations, research institutions, and pharmaceutical companies has been instrumental in driving market growth. The region benefits from significant government funding for genomics research, well-established regulatory frameworks, and increasing applications in clinical diagnostics and personalized medicine.

Market Analysis of DNA Sequencing Market: Forecasted Growth Rate by Region

DNA Sequencing Market in the United States

The United States maintains its position as the largest market for DNA sequencing in North America, commanding approximately 87% of the regional market share. The country's market dominance is supported by its extensive network of research institutions, biotechnology companies, and healthcare facilities. The presence of leading market players, coupled with substantial investments in genomics research and development, continues to drive innovation in sequencing technologies. The country's robust healthcare system, advanced technological infrastructure, and increasing focus on precision medicine have created a favorable environment for market growth. The adoption of DNA sequencing in clinical diagnostics, drug discovery, and personalized medicine applications continues to expand, supported by favorable reimbursement policies and healthcare regulations.

DNA Sequencing Market in Canada

Canada emerges as the fastest-growing market in North America, with a projected CAGR of approximately 21% during 2024-2029. The country's rapid growth is driven by increasing investments in genomics research, expanding applications in clinical diagnostics, and growing adoption of next-generation sequencing technologies. Canadian research institutions and healthcare organizations are actively participating in large-scale genomics projects, contributing to market expansion. The country's focus on developing its biotechnology sector, combined with government initiatives supporting genomics research, has created a dynamic environment for market growth. The integration of DNA sequencing in healthcare delivery and personalized medicine approaches continues to gain momentum across Canadian healthcare institutions.

DNA Sequencing Market in Europe

Europe represents a significant market for DNA sequencing technologies, with a strong presence across Germany, the United Kingdom, France, Italy, and Spain. The region's market is characterized by robust research infrastructure, advanced healthcare systems, and significant investments in genomics research. European countries have demonstrated a strong commitment to advancing genomic medicine through various national and regional initiatives. The presence of leading research institutions, biotechnology companies, and healthcare organizations continues to drive innovation and adoption of sequencing technologies across the region.

DNA Sequencing Market in Germany

Germany stands as both the largest and fastest-growing market in Europe, holding approximately 22% of the regional market share. The country's leadership position is supported by its advanced healthcare infrastructure, strong research capabilities, and significant investments in biotechnology. German research institutions and healthcare organizations have been at the forefront of adopting innovative sequencing technologies for both research and clinical applications. The country's robust pharmaceutical and biotechnology sectors, combined with substantial government support for genomics research, continue to drive market growth.

DNA Sequencing Market Growth in Germany

Germany's DNA sequencing market demonstrates exceptional growth potential, with a projected CAGR of approximately 22% during 2024-2029. The country's rapid market expansion is driven by increasing adoption of next-generation sequencing technologies in clinical diagnostics, growing applications in personalized medicine, and rising investments in genomics research. German healthcare institutions are increasingly incorporating DNA sequencing into routine clinical practice, particularly in oncology and rare disease diagnostics. The country's strong focus on technological innovation and research excellence continues to attract investments and foster market growth.

DNA Sequencing Market in Asia-Pacific

The Asia-Pacific region represents a dynamic market for DNA sequencing, encompassing major economies including China, Japan, India, Australia, and South Korea. The region demonstrates significant growth potential driven by increasing healthcare expenditure, rising adoption of advanced genomic technologies, and growing research activities. Government initiatives supporting genomics research, expanding biotechnology sectors, and increasing awareness about personalized medicine contribute to market expansion across the region. The development of local sequencing capabilities and growing participation in international genomics projects further strengthen the market landscape.

DNA Sequencing Market in Japan

Japan emerges as the largest market for DNA sequencing in the Asia-Pacific region, supported by its advanced healthcare infrastructure and strong research capabilities. The country's leadership in technological innovation, combined with significant investments in genomics research, drives market growth. Japanese healthcare institutions and research organizations demonstrate strong adoption of advanced sequencing technologies, particularly in cancer research and precision medicine applications. The country's aging population and focus on preventive healthcare create sustained demand for sequencing services and technologies.

DNA Sequencing Market in China

China represents the fastest-growing market in the Asia-Pacific region, driven by rapid technological advancement and increasing investments in biotechnology. The country's expanding healthcare infrastructure, growing research capabilities, and government support for genomics initiatives contribute to market growth. Chinese institutions are increasingly participating in large-scale sequencing projects, while local companies continue to develop innovative sequencing technologies. The country's focus on building domestic capabilities in genomics and precision medicine creates substantial opportunities for market expansion.

DNA Sequencing Market in Middle East & Africa

The Middle East & Africa region demonstrates growing adoption of DNA sequencing technologies, with GCC countries and South Africa leading market development. The region's market is characterized by increasing healthcare expenditure, growing awareness about genetic testing, and rising investments in research infrastructure. GCC countries emerge as both the largest and fastest-growing market in the region, driven by substantial healthcare investments and modernization initiatives. The region's focus on developing advanced healthcare capabilities and increasing adoption of precision medicine approaches continues to create opportunities for market expansion. Research institutions and healthcare organizations across the region are increasingly incorporating sequencing technologies into their diagnostic and research programs.

DNA Sequencing Market in South America

The South American DNA sequencing market, led by Brazil and Argentina, shows promising growth potential driven by increasing investments in healthcare infrastructure and research capabilities. Brazil emerges as both the largest and fastest-growing market in the region, supported by its expanding biotechnology sector and growing adoption of advanced genomic technologies. The region's market development is characterized by increasing participation in international genomics projects, rising awareness about genetic testing, and growing applications in clinical diagnostics. Government initiatives supporting research and development in genomics, combined with improving healthcare infrastructure, continue to drive market expansion across South America. The region demonstrates growing adoption of next-generation sequencing technologies, particularly in academic research and clinical applications.

DNA Sequencing Industry Overview

Top Companies in DNA Sequencing Market

The DNA sequencing market features prominent players like Illumina, Thermo Fisher Scientific, Agilent Technologies, Roche, and Merck KGaA leading the competitive landscape through continuous innovation and strategic expansion. These DNA sequencing companies are heavily investing in research and development to advance their sequencing technologies, particularly in next-generation sequencing platforms and associated consumables. The industry witnesses frequent strategic collaborations and partnerships, especially in developing diagnostic solutions and expanding geographical reach. Companies are increasingly focusing on developing integrated workflow solutions that combine hardware, reagents, and bioinformatics capabilities. Market leaders are also emphasizing the development of automated, high-throughput systems while simultaneously working to reduce sequencing costs and improve accessibility. The competitive dynamics are further shaped by investments in emerging technologies like third-generation sequencing and artificial intelligence-powered analysis tools.

Consolidated Market with Strong Growth Potential

The DNA sequencing market exhibits a relatively consolidated structure dominated by large multinational corporations with extensive research capabilities and global distribution networks. These major genome sequencing companies leverage their comprehensive product portfolios, established brand presence, and strong financial resources to maintain their market positions. The industry is characterized by significant barriers to entry due to high technological requirements, substantial capital investments, and complex regulatory frameworks. Market leaders are increasingly pursuing vertical integration strategies, controlling everything from instrument manufacturing to reagent production and data analysis solutions.


The market demonstrates active merger and acquisition activity, with larger companies regularly acquiring innovative startups and smaller technology firms to enhance their technological capabilities and expand their market presence. Companies are particularly interested in acquiring firms with complementary technologies or strong regional presence in emerging markets. The competitive landscape is further influenced by academic and research institutions that often collaborate with commercial entities for technology development and validation. Regional players are gaining prominence in specific geographic markets, particularly in Asia-Pacific, where they leverage local market knowledge and government support to compete with global players.

Innovation and Accessibility Drive Market Success

Success in the DNA sequencing market increasingly depends on companies' ability to balance technological advancement with cost-effectiveness and user-friendly solutions. Market leaders must focus on developing comprehensive ecosystem solutions that include not just sequencing platforms but also sample preparation, data analysis, and storage capabilities. Companies need to invest in artificial intelligence and machine learning capabilities to enhance data interpretation and analysis capabilities while simultaneously working to reduce the complexity of their systems. Building strong relationships with healthcare providers, research institutions, and pharmaceutical companies is becoming crucial for maintaining market share.


For emerging players and contenders, success lies in identifying and focusing on specific market niches or applications where they can develop specialized expertise. Companies must consider the growing importance of personalized medicine and clinical diagnostics while developing their market strategies. The regulatory landscape continues to evolve, particularly regarding clinical applications and data privacy, requiring companies to maintain robust compliance frameworks. Future success will also depend on addressing the increasing demand for point-of-care solutions and the ability to provide comprehensive support services. Companies must also consider the growing influence of healthcare systems and large research institutions in purchasing decisions, necessitating strong value propositions and clear differentiation strategies.

DNA Sequencing Market Leaders

  1. Merck KGaA

  2. Thermo Fisher Scientific, Inc.

  3. Agilent Technologies, Inc.

  4. Illumina, Inc.

  5. F. Hoffmann-La Roche Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
Picture5.png
Need More Details on Market Players and Competiters?
Download PDF

DNA Sequencing Market News

  • In October 2022, PacBio has announced the release of two genome sequencing systems, the Revio long-read sequencing system and the Onso short-read sequencing system. Deep-learning methods are also integrated into Revio to detect DNA methylation from regular sequencing libraries.
  • In March 2022, Element Biosciences revealed technical details about its long-awaited Aviti DNA sequencer. The new benchtop instrument employs a riff on sequencing-by-synthesis chemistry that Element says reduces reagent usage, leading to costs of approximately USD 7 per Gb.

DNA Sequencing Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Technological Advancements in DNA Sequencing
    • 4.2.2 Increasing Application in Clinical Diagnosis and Drug Discovery
    • 4.2.3 Growing Investments in R&D
  • 4.3 Market Restraints
    • 4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals
    • 4.3.2 Legal and Ethical Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Instruments
    • 5.1.2 Consumables (Kits and Reagents)
    • 5.1.3 Other Product Types
  • 5.2 By Sequencing Type
    • 5.2.1 Sanger Sequencing
    • 5.2.2 Next-generation Sequencing
    • 5.2.3 Other Sequencing Types
  • 5.3 By Application
    • 5.3.1 Diagnostics
    • 5.3.2 Personalized Medicine
    • 5.3.3 Other Applications
  • 5.4 By End User
    • 5.4.1 Hospitals and Healthcare Organizations
    • 5.4.2 Academics and Research Institutions
    • 5.4.3 Pharmaceutical and Biotechnology Companies
    • 5.4.4 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 Bio-Rad Laboratories Inc.
    • 6.1.3 Danaher Corporation (Integrated DNA Technologies Inc.)
    • 6.1.4 F. Hoffmann-La Roche Ltd
    • 6.1.5 Illumina Inc.
    • 6.1.6 Merck KGaA
    • 6.1.7 PerkinElmer Inc.
    • 6.1.8 Thermo Fisher Scientific Inc.
    • 6.1.9 QIAGEN
    • 6.1.10 Macrogen Inc.
    • 6.1.11 Myriad Genetics Inc.
    • 6.1.12 Eurofins Scientific
    • 6.1.13 Hamilton Thorne Biosciences
    • 6.1.14 Pacific Biosciences of California Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

DNA Sequencing Industry Segmentation

As per the scope of the report, DNA sequencing is the procedure of determining or identifying the sequence of nucleotides within a DNA molecule. This information is useful for researchers in understanding the type of genetic information that is carried in the DNA, which may affect its function in the body. It can then, in turn, help to detect genetic changes that may be associated with causing certain health conditions. The DNA Sequencing Market is Segmented by Product Type (Instruments, Consumables, and Other Product Types), Sequencing Type (Sanger Sequencing, Next-generation Sequencing, and Other Sequencing Types), Application (Diagnostics, Personalized Medicine, and Other Applications), End User (Hospitals and Healthcare Organizations, Academics and Research Institutions, Pharmaceutical and Biotechnology Companies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also studies the biopharmaceuticals market in 17 different countries across major regions across the world. The report offers the value (in USD million) for the above segments.

By Product Type Instruments
Consumables (Kits and Reagents)
Other Product Types
By Sequencing Type Sanger Sequencing
Next-generation Sequencing
Other Sequencing Types
By Application Diagnostics
Personalized Medicine
Other Applications
By End User Hospitals and Healthcare Organizations
Academics and Research Institutions
Pharmaceutical and Biotechnology Companies
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

DNA Sequencing Market Research FAQs

How big is the DNA Sequencing Market?

The DNA Sequencing Market size is expected to reach USD 14.40 billion in 2025 and grow at a CAGR of 18.91% to reach USD 34.23 billion by 2030.

What is the current DNA Sequencing Market size?

In 2025, the DNA Sequencing Market size is expected to reach USD 14.40 billion.

Who are the key players in DNA Sequencing Market?

Merck KGaA, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc. and F. Hoffmann-La Roche Ltd. are the major companies operating in the DNA Sequencing Market.

Which is the fastest growing region in DNA Sequencing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in DNA Sequencing Market?

In 2025, the North America accounts for the largest market share in DNA Sequencing Market.

What years does this DNA Sequencing Market cover, and what was the market size in 2024?

In 2024, the DNA Sequencing Market size was estimated at USD 11.68 billion. The report covers the DNA Sequencing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the DNA Sequencing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

DNA Sequencing Market Research

Mordor Intelligence offers extensive expertise in analyzing the DNA sequencing market and the genome sequencing industry. We provide comprehensive insights into this rapidly evolving sector. Our detailed research covers DNA sequencing companies, gene sequencing equipment manufacturers, and various sequencing technologies that are transforming healthcare and research. The report offers an in-depth analysis of DNA sequencing products and services, including both long read sequencing and traditional methods. It is available as an easy-to-download report PDF.

Our analysis benefits stakeholders by offering detailed insights into genome sequencing market size trends and DNA sequencing market growth projections. The report covers key regions, including the North America DNA sequencing market and emerging markets. It also examines the latest developments in whole genome sequencing technologies. Stakeholders gain valuable information about gene sequencing machine manufacturers, genomic sequencing companies, and the evolving landscape of DNA sequencing services. This enables informed decision-making in this dynamic industry.